Quick text search:

>>> Receptor search

>>> Ligand search

REFERENCES

Adham, N., Bard, J. A., Zgombick, J. M., Durkin, M. M., Kucharewicz, S., Weinshank, R. L. and Branchek, T. A. (1997) 
Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog.
Neuropharmacology, 36: 569-576. [PMID:9225282]

Adham, N., Borden, L. A., Schechter, L. E., Gustafson, E. L., Cochran, T. L., Vaysse, P. J., Weinshank, R. L. and Branchek, T. A. (1993) 
Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways.
Naunyn Schmiedebergs Arch Pharmacol, 348: 566-575. [PMID:8133900]

Adham, N., Gerald, C., Schechter, L., Vaysse, P., Weinshank, R. and Branchek, T. (1996) 
[3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
Eur J Pharmacol, 304: 231-235. [PMID:8813606]

Adham, N., Kao, H. T., Schecter, L. E., Bard, J., Olsen, M., Urquhart, D., Durkin, M., Hartig, P. R., Weinshank, R. L. and Branchek, T. A. (1993) 
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
Proc Natl Acad Sci U S A, 90: 408-412. [PMID:8380639]

Adham, N., Romanienko, P., Hartig, P., Weinshank, R. L. and Branchek, T. (1992) 
The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
Mol Pharmacol, 41: 1-7. [PMID:1732716]

Adham, N., Vaysse, P. J., Weinshank, R. L. and Branchek, T. A. (1994) 
The cloned human 5-HT1E receptor couples to inhibition and activation of adenylyl cyclase via two distinct pathways in transfected BS-C-1 cells.
Neuropharmacology, 33: 403-410. [PMID:7984278]

Adham, N., Zgombick, J. M., Bard, J. and Branchek, T. A. (1998) 
Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
J Pharmacol Exp Ther, 287: 508-514. [PMID:9808674]

Albert, P. R., Sajedi, N., Lemonde, S. and Ghahremani, M. H. (1999) 
Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists.
J Biol Chem, 274: 35469-35474. [PMID:10585418]

Albert, P. R., Zhou, Q. Y., Van Tol, H. H., Bunzow, J. R. and Civelli, O. (1990) 
Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene.
J Biol Chem, 265: 5825-5832. [PMID:2156831]

Almaula, N., Ebersole, B. J., Zhang, D., Weinstein, H. and Sealfon, S. C. (1996) 
Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin.
J Biol Chem, 271: 14672-14675. [PMID:8663249]

Amlaiky, N; Ramboz, S; Boschert, U; Plassat, JL; Hen, R. (1992) 
Isolation of a mouse "5HT1E-like" serotonin receptor expressed predominantly in hippocampus.
J. Biol. Chem., 267 (28): 19761-4. [PMID:1328180]

Asakawa, A., Ueno, N., Katagi, M., Ijuin, Y., Morita, Y., Mizuno, S., Inui, T., Sakamaki, R., Shinfuku, N. and Uemoto, M. (2006) 
Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying.
J Diabetes Complications, 20: 56-58. [PMID:16389169]

Ase, A. R., Reader, T. A., Hen, R., Riad, M. and Descarries, L. (2000) 
Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice.
J Neurochem, 75: 2415-2426. [PMID:11080193]

Ase, A. R., Reader, T. A., Hen, R., Riad, M. and Descarries, L. (2001) 
Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.
J Neurochem, 78: 619-630. [PMID:11483665]

Aznar, S., Qian, Z., Shah, R., Rahbek, B. and Knudsen, G. M. (2003) 
The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain.
Brain Res, 959: 58-67. [PMID:12480158]

Bach, T., Syversveen, T., Kvingedal, A. M., Krobert, K. A., Brattelid, T., Kaumann, A. J. and Levy, F. O. (2001) 
5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Naunyn Schmiedebergs Arch Pharmacol, 363: 146-160. [PMID:11218067]

Bagdy, G., Graf, M., Anheuer, Z. E., Modos, E. A. and Kantor, S. (2001) 
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Int J Neuropsychopharmaco, 4: 399-408. [PMID:11806866]

Bai, F., Yin, T., Johnstone, E. M., Su, C., Varga, G., Little, S. P. and Nelson, D. L. (2004) 
Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor.
Eur J Pharmacol, 484: 127-139. [PMID:14744596]

Baker, L. P., Nielsen, M. D., Impey, S., Metcalf, M. A., Poser, S. W., Chan, G., Obrietan, K., Hamblin, M. W. and Storm, D. R. (1998) 
Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor.
J Biol Chem, 273: 17469-17476. [PMID:9651336]

Banasr, M., Hery, M., Printemps, R. and Daszuta, A. (2004) 
Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone.
Neuropsychopharmacology, 29: 450-460. [PMID:14872203]

Banes, A., Florian, J. A. and Watts, S. W. (1999) 
Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
J Pharmacol Exp Ther, 291: 1179-1187. [PMID:10565840]

Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A. and Weinshank, R. L. (1993) 
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
J Biol Chem, 268: 23422-23426. [PMID:8226867]

Bartsch, T., Knight, Y. E. and Goadsby, P. J. (2004) 
Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception.
Ann Neurol, 56: 371-381. [PMID:15349864]

Baxter, G. S., Craig, D. A. and Clarke, D. E. (1991) 
5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae.
Naunyn Schmiedebergs Arch Pharmacol, 343: 439-446. [PMID:1881455]

Beattie, D. T., Smith, J. A., Marquess, D., Vickery, R. G., Armstrong, S. R., Pulido-Rios, T., McCullough, J. L., Sandlund, C., Richardson, C., Mai, N. and Humphrey, P. P. (2004) 
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
Br J Pharmacol, 143: 549-560. [PMID:15466450]

Belenky, M. A. and Pickard, G. E. (2001) 
Subcellular distribution of 5-HT(1B) and 5-HT(7) receptors in the mouse suprachiasmatic nucleus.
J Comp Neurol, 432: 371-388. [PMID:11246214]

Bender, E., Pindon, A., van Oers, I., Zhang, Y. B., Gommeren, W., Verhasselt, P., Jurzak, M., Leysen, J. and Luyten, W. (2000) 
Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant.
J Neurochem., 74: 478-489. [PMID:10646498]

Bentley, J. C., Bourson, A., Boess, F. G., Fone, K. C., Marsden, C. A., Petit, N. and Sleight, A. J. (1999) 
Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.
Br J Pharmacol, 126: 1537-1542. [PMID:10323584]

Berg, K. A., Cropper, J. D., Niswender, C. M., Sanders-Bush, E., Emeson, R. B. and Clarke, W. P. (2001) 
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Br J Pharmacol, 134: 386-392. [PMID:11564657]

Bergen, A. W., van den Bree, M. B., Yeager, M., Welch, R., Ganjei, J. K., Haque, K., Bacanu, S., Berrettini, W. H., Grice, D. E., Goldman, D., Bulik, C. M., Klump, K., Fichter, M., Halmi, K., Kaplan, A., Strober, M., Treasure, J., Woodside, B. and Kaye, W. H. (2003) 
Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa.
Mol Psychiatry, 8: 397-406. [PMID:12740597]

Berque-Bestel, I., Soulier, J. L., Giner, M., Rivail, L., Langlois, M. and Sicsic, S. (2003) 
Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
J Med Chem, 46: 2606-2620. [PMID:12801225]

Bert, B., Dere, E., Wilhelmi, N., Kusserow, H., Theuring, F., Huston, J. P. and Fink, H. (2005) 
Transient overexpression of the 5-HT1A receptor impairs water-maze but not hole-board performance.
Neurobiol Learn Mem, 84: 57-68. [PMID:15936683]

Blair, J. B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L. and Nichols, D. E. (2000) 
Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
J Med Chem, 43: 4701-4710. [PMID:11101361]

Blondel, O., Gastineau, M., Dahmoune, Y., Langlois, M. and Fischmeister, R. (1998) 
Cloning, expression and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
J. Neurochem., 70: 2252-2261. [PMID:9603189]

Blondel, O., Vandecasteele, G., Gastineau, M., Leclerc, S., Dahmoune, Y., Langlois, M. and Fischmeister, R. (1997) 
Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium.
FEBS Lett, 412: 465-474. [PMID:9276448]

Bockaert, J., Claeysen, S., Compan, V. and Dumuis, A. (2004) 
5-HT4 receptors.
Curr Drug Targets CNS Neurol Disord., 3: 39-51. [PMID:14965243]

Bockaert, J., Sebben, M. and Dumuis, A. (1990) 
Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.
Mol Pharmacol., 37: 408-411. [PMID:2314390]

Boddeke, H. W., Hoffman, B. J., Palacios, J. M., Knot, H. and Hoyer, D. (1993) 
Characterization of functional responses in A9 cells transfected with cloned rat 5-HT1C receptors.
Naunyn Schmiedebergs Arch Pharmacol, 347: 119-124. [PMID:8474532]

Boess, F. G., Monsma, F. J. and Sleight, A. J. (1998) 
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
J Neurochem, 71: 2169-2177. [PMID:9798944]

Boess, F. G., Monsma, F. J., Carolo, C., Meyer, V., Rudler, A., Zwingelstein, C. and Sleight, A. J. (1997) 
Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.
Neuropharmacology, 36: 713-720. [PMID:9225298]

Boess, F. G., Monsma, F. J., Meyer, V., Zwingelstein, C. and Sleight, A. J. (1997) 
Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
Mol Pharmacol, 52: 515-523. [PMID:9284367]

Boess, F. G., Riemer, C., Bos, M., Bentley, J., Bourson, A. and Sleight, A. J. (1998) 
The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
Mol Pharmacol, 54: 577-583. [PMID:9730917]

Bonaventure, P., Hall, H., Gommeren, W., Cras, P., Langlois, X., Jurzak, M. and Leysen, J. E. (2000) 
Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain.
Synapse., 36: 35-46. [PMID:10700024]

Bonaventure, P., Schotte, A., Cras, P. and , . (1997) 
Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand.
Receptors Channels, 5: 225-230. [PMID:9606727]

Bonhaus, D. W., Berger, J., Adham, N., Branchek, T. A., Hsu, S. A., Loury, D. N., Leung, E., Wong, E. H., Clark, R. D. and Eglen, R. M. (1997) 
[3H]RS 57639, a high affinity, selective 5-HT4 receptor partial agonist, specifically labels guinea-pig striatal and rat cloned (5-HT4S and 5-HT4L) receptors.
Neuropharmacology, 36: 671-679. [PMID:9225293]

Bonhaus, D. W., Flippin, L. A., Greenhouse, R. J., Jaime, S., Rocha, C., Dawson, M., Van Natta, K., Chang, L. K., Pulido-Rios, T., Webber, A., Leung, E., Eglen, R. M. and Martin, G. R. (1999) 
RS-127445: a selective, high affinity, orally bioavailable 5-HT_2B receptor antagonist.
Br. J. Pharmacol., 127: 1075-1082. [PMID:10455251]

Bonhaus, D. W., Weinhardt, K. K., Taylor, M., DeSouza, A., McNeeley, P. M., Szczepanski, K., Fontana, D. J., Trinh, J., Rocha, C. L., Dawson, M. W., Flippin, L. A. and Eglen, R. M. (1977) 
RS-102221: a novel high affinity and selective, 5-HT_2C receptor antagonist.
Neuropharmacology, 36: 621-9. [PMID:9225287]

Bortolozzi, A., Amargos-Bosch, M., Toth, M., Artigas, F. and Adell, A. (2004) 
In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.
J Neurochem, 88: 1373-1379. [PMID:15009637]

Boulenguez, P; Segu, L; Chauveau, J; Morel, A; Lanoir, J; Delaage, M. (1992) 
Biochemical and pharmacological characterization of serotonin-O-carboxymethylglycyl[125I]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites.
J. Neurochem., 58 (3): 951-9. [PMID:1738002]

Bourson, A., Boess, F. G., Bos, M. and Sleight, A. J. (1998) 
Involvement of 5-HT6 receptors in nigro-striatal function in rodents.
Br J Pharmacol, 125: 1562-1566. [PMID:9884085]

Bourson, A., Borroni, E., Austin, R. H., Monsma, F. J. and Sleight, A. J. (1994) 
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides.
J Pharmacol Exp Ther, 275: 173-180. [PMID:7616396]

Boutrel, B., Monaca, C., Hen, R., Hamon, M. and Adrien, J. (2002) 
Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice.
J Neurosci, 22: 4686-4692. [PMID:12040075]

Branchek, T., Adham, N., Macchi, M., Kao, H. T. and Hartig, P. R. (1990) 
[3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
Mol Pharmacol, 38: 604-609. [PMID:2233697]

Brattelid, T., Kvingedal, A. M., Krobert, K. A., Andressen, K. W., Bach, T., Hystad ME,Kaumann, A. J. and Levy, F. O. (2004) 
Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).
Naunyn Schmiedebergs Arch Pharmacol., 369: 616-628. [PMID:15118808]

Brenchat, A; Romero, L; García, M; Pujol, M; Burgueño, J; Torrens, A; Hamon, M; Baeyens, JM; Buschmann, H; Zamanillo, D; et al.. (2009) 
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice.
Pain, 141 (3): 239-47. [PMID:19118950]

Brennan, T. J., Seeley, W. W., Kilgard, M., Schreiner, C. E. and Tecott, L. H. (1997) 
Sound-induced seizures in serotonin 5-HT2c receptor mutant mice.
Nat Genet, 16: 387-390. [PMID:9241279]

Briejer, M. R., Bosmans, J. P., Van Daele, P., Jurzak, M., Heylen, L., Leysen, J. E., Prins, N. H. and Schuurkes, J. A. (2001) 
The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound.
Eur J Pharmacol, 423: 71-83. [PMID:11438309]

Bromidge, S. M., Brown, A. M., Clarke, S. E., Dodgson, K., Gager, T., Grassam, H. L., Jeffrey, P. M., Joiner, G. F., King, F. D., Middlemiss, D. N., Moss, S. F., Newman, H., Riley, G., Routledge, C. and Wyman, P. (1999) 
5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.
J Med Chem, 42: 202-205. [PMID:9925723]

Bromidge, S. M., Dabbs, S., Davies, D. T., Davies, S., Duckworth, D. M., Forbes, I. T., Gaster, L. M., Ham, P., Jones, G. E., King, F. D., Mulholland, K. R., Saunders, D. V., Wyman, P. A., Blaney, F. E., Clarke, S. E., Blackburn, T. P., Holland, V., Kennett, G. A., Lightowler, S., Middlemiss, D. N., Trail, B., Riley, G. J. and Wood, M. D. (2000) 
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
J Med Chem, 43: 1123-1134. [PMID:10737744]

Bromidge, SM; Clarke, SE; Gager, T; Griffith, K; Jeffrey, P; Jennings, AJ; Joiner, GF; King, FD; Lovell, PJ; Moss, SF; et al.. (2001) 
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
Bioorg. Med. Chem. Lett., 11 (1): 55-8. [PMID:11140733]

Brown, A.M., Avenell, K., Young, T.J., Ho, M., Porter, R.A., Vimal, M and Middlemiss, D.N. (1998) 
BRL 54443, a potent agonist with selectivity for human cloned 5-HT1E and 5-HT1F receptors.
British Journal of Pharmacology, 123 (1): 233.

Bruinvels, A. T., Landwehrmeyer, B., Gustafson, E. L., Durkin, M. M., Mengod, G., Branchek, T. A., Hoyer, D. and Palacios, J. M. (1994) 
Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain.
Neuropharmacology, 33: 367-386. [PMID:7984275]

Bruss, M., Kiel, S., Bonisch, H., Kostanian, A. and Gothert, M. (2005) 
Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Neurochem Int, 47: 196-203. [PMID:15896881]

Bryant, H. U., Nelson, D. L., Button, D., Cole, H. W., Baez, M. B., Lucaites, V. L., Wainscott, D. B., Whitesitt, C., Reel, J., Simon, R. and Koppel, G. A. (1996) 
A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines.
Life Sci, 59: 1259-1268. [PMID:8845011]

Buckland, P. R., Hoogendoorn, B., Guy, C. A., Smith, S. K., Coleman, S. L. and O'Donovan, M. C. (2005) 
Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain.
Am J Psychiatry, 162: 613-615. [PMID:15741483]

Budhoo, M. R. and Kellum, J. M. (1994) 
Evidence for a 5-HT4 receptor pathway mediating chloride secretion in the rat distal colon.
J Surg Res, 57: 44-48. [PMID:8041147]

Buhot, M. C. and Naili, S. (1995) 
Changes in exploratory activity following stimulation of hippocampal 5-HT1A and 5-HT1B receptors in the rat.
Hippocampus, 5: 198-208. [PMID:7550615]

Burnet, P. W., Eastwood, S. L., Lacey, K. and Harrison, P. J. (1995) 
The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.
Brain Res, 676: 157-168. [PMID:7796165]

Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E. and Emeson, R. B. (1997) 
Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
Nature, 387: 303-308. [PMID:9153397]

Bymaster, F. P., Dreshfield-Ahmad, L. J., Threlkeld, P. G., Shaw, J. L., Thompson, L., Nelson, D. L., Hemrick-Luecke, S. K. and Wong, D. T. (2001) 
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Neuropsychopharmacology, 25: 871-880. [PMID:11750180]

Canton, H., Emeson, R. B., Barker, E. L., Backstrom, J. R., Lu, J. T., Chang, M. S. and Sanders-Bush, E. (1996) 
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.
Mol Pharmacol, 50: 799-807. [PMID:8863824]

Carson, M. J., Thomas, E. A., Danielson, P. E. and Sutcliffe, J. G. (1996) 
The 5HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes.
Glia, 17: 317-326. [PMID:8856328]

Castro, L., Mialet-Perez, J., Guillemeau, A., Stillitano, F., Zolk, O., Eschenhagen, T., Lezoualc'h, F., Bochet, P. and Fischmeister, R. (2005) 
Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.
J Mol Cell Cardiol, 39: 335-344. [PMID:15950987]

Centurion, D., Glusa, E., Sanchez-Lopez, A., Valdivia, L. F., Saxena, P. R. and Villalon, C. M. (2004) 
5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats.
Eur J Pharmacol, 502: 239-242. [PMID:15476750]

Chadha, A., Sur, C., Atack, J. and Duty, S. (2000) 
The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat.
Br J Pharmacol, 130: 1927-1932. [PMID:10952684]

Chapin, E. M. and Andrade, R. (2001) 
A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h).
J Pharmacol Exp Ther, 297: 403-409. [PMID:11259569]

Charest, A., Wainer, B. H. and Albert, P. R. (1993) 
Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line.
J Neurosci, 13: 5164-5171. [PMID:8254366]

Chen, J., Shen, C. and Meller, E. (2002) 
5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain.
Eur J Pharmacol, 452: 155-162. [PMID:12354565]

Choi, D. S. and Maroteaux, L. (1996) 
Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain.
FEBS Lett, 391: 45-51. [PMID:8706927]

Chojnacka-Wojcik, E., Klodzinska, A. and Deren-Wesolek, A. (1994) 
Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
Pol J Pharmacol, 46: 423-428. [PMID:7894529]

Chou-Green, J. M., Holscher, T. D., Dallman, M. F. and Akana, S. F. (2003) 
Repeated stress in young and old 5-HT(2C) receptor knockout mice.
Physiol Behav, 79: 217-226. [PMID:12834793]

Chou-Green, J. M., Holscher, T. D., Dallman, M. F. and Akana, S. F. (2003) 
Compulsive behavior in the 5-HT2C receptor knockout mouse.
Physiol Behav, 78: 641-649. [PMID:12782219]

Claeysen, S., Faye, P., Sebben, M., Lemaire, S., Bockaert, J. and Dumuis, A. (1997) 
Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase.
Neuroreport., 8: 3189-3196. [PMID:9351641]

Claeysen, S., Sebben, M., Becamel, C., Bockaert, J. and Dumuis, A. (1999) 
Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain.
Mol Pharmacol., 55: 910-920. [PMID:10220570]

Claeysen, S., Sebben, M., Journot, L., Bockaert, J. and Dumuis, A. (1996) 
Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor.
FEBS Lett, 398: 19-25. [PMID:8946946]

Compan, V., Charnay, Y., Dusticier, N., Daszuta, A., Hen, R. and Bockaert, J. (2004) 
Feeding disorders in 5-HT4 receptor knockout mice.
J Soc Biol., 198: 37-49. [PMID:15146954]

Compan, V., Daszuta, A., Salin, P., Sebben, M., Bockaert, J. and Dumuis, A. (1996) 
Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus.
Eur J Neurosci., 8: 2591-2598. [PMID:8996808]

Compan, V., Zhou, M., Grailhe, R., Gazzara, R. A., Martin, R., Gingrich, J., Dumuis, A., Brunner, D., Bockaert, J. and Hen, R. (2004) 
Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice.
J Neurosci., 24: 412-419. [PMID:14724239]

Conn, P. J., Sanders-Bush, E., Hoffman, B. J. and Hartig, P. R. (1986) 
A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
Proc Natl Acad Sci U S A, 83: 4086-4088. [PMID:2940597]

Corbett, D. F., Heightman, T. D., Moss, S. F., Bromidge, S. M., Coggon, S. A., Longley, M. J., Roa, A. M., Williams, J. A. and Thomas, D. R. (2005) 
Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
Bioorg Med Chem Lett, 15: 4014-4018. [PMID:16002289]

Cox, D. A. and Cohen, M. L. (1995) 
5-Hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C.
J Pharmacol Exp Ther, 272: 143-150. [PMID:7815326]

Crowell, M. D., Mathis, C., Schettler, V. A., Yunus, T. and Lacy, B. E. (2005) 
The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus.
Neurogastroenterol Motil, 17: 738-743. [PMID:16185313]

Darblade, B., Behr-Roussel, D., Gorny, D., Lebret, T., Benoit, G., Hieble, J. P., Brooks, D., Alexandre, L. and Giuliano, F. (2005) 
Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle.
World J Urol, 23: 147-151. [PMID:15902472]

Davidson, C., Ho, M., Price, G. W., Jones, B. J. and Stamford, J. A. (1997) 
(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.
Br J Pharmacol, 121: 737-742. [PMID:9208142]

Day, M., Olson, P. A., Platzer, J., Striessnig, J. and Surmeier, D. J. (2002) 
Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade.
J Neurophysiol, 87: 2490-2504. [PMID:11976386]

De Vry, J., Schohe-Loop, R., Heine, H. G., Greuel, J. M., Mauler, F., Schmidt, B., Sommermeyer, H. and Glaser, T. (1998) 
Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
J Pharmacol Exp Ther, 284: 1082-1094. [PMID:9495870]

Degen, L., Matzinger, D., Merz, M., Appel-Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H. and Beglinger, C. (2001) 
Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
Aliment Pharmacol Ther, 15: 1745-1751. [PMID:11683688]

Del Tredici, A. L., Schiffer, H. H., Burstein, E. S., Lameh, J., Mohell, N., Hacksell, U., Brann, M. R. and Weiner, D. M. (2004) 
Pharmacology of polymorphic variants of the human 5-HT1A receptor.
Biochem Pharmacol, 67: 479-490. [PMID:15037200]

Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N. and Abrahamsson, P. A. (2004) 
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
Prostate, 59: 328-336. [PMID:15042609]

Doly, S., Fischer, J., Brisorgueil, M. J., Verge, D. and Conrath, M. (2004) 
5-HT5A receptor localization in the rat spinal cord suggests a role in nociception and control of pelvic floor musculature.
J Comp Neurol, 476: 316-329. [PMID:15282708]

Domenech, T., Beleta, J. and Palacios, J. M. (1997) 
Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Naunyn Schmiedebergs Arch Pharmacol, 356: 328-334. [PMID:9303569]

Domenech, T., Beleta, J., Fernandez, A. G., Gristwood, R. W., Cruz Sanchez, F., Tolosa, E. and Palacios, J. M. (1994) 
Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species.
Brain Res Mol Brain Res, 21: 176-180. [PMID:8164518]

Dukat, M., Smith, C., Herrick-Davis, K., Teitler, M. and Glennon, R. A. (2004) 
Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.
Bioorg Med Chem, 12: 2545-2552. [PMID:15110837]

Dumuis, A., Bouhelal, R., Sebben, M., Cory, R. and Bockaert, J. (1988) 
A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Mol Pharmacol., 34: 880-887. [PMID:2849052]

Dunlop, J., Sabb, A. L., Mazandarani, H., Zhang, J., Kalgaonker, S., Shukhina, E., Sukoff, S., Vogel, R. L., Stack, G., Schechter, L., Harrison, B. L. and Rosenzweig-Lipson, S. (2005) 
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1h i]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
J Pharmacol Exp Ther, 313: 862-869. [PMID:15705738]

Egan, C. T., Herrick-Davis, K. and Teitler, M. (1998) 
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
J Pharmacol Exp Ther, 286: 85-90. [PMID:9655845]

Egan, C., Grinde, E., Dupre, A., Roth, B. L., Hake, M., Teitler, M. and Herrick-Davis, K. (2000) 
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
Synapse, 35: 144-150. [PMID:10611640]

El-Khodor, B. F., Dimmler, M. H., Amara, D. A., Hofer, M., Hen, R. and Brunner, D. (2004) 
Juvenile 5HT(1B) receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT(1A) receptor activation.
Int J Dev Neurosci, 22: 405-413. [PMID:15380839]

Ellis, E. S., Byrne, C., Murphy, O. E., Tilford, N. S. and Baxter, G. S. (1995) 
Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein.
Br J Pharmacol, 114: 400-404. [PMID:7881740]

Ennis, MD; Ghazal, NB; Hoffman, RL; Smith, MW; Schlachter, SK; Lawson, CF; Im, WB; Pregenzer, JF; Svensson, KA; Lewis, RA; et al.. (1998) 
Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.
J. Med. Chem., 41 (13): 2180-3. [PMID:9632349]

Erlander, M. G., Lovenberg, T. W., Baron, B. M., De Lecea, L., Danielson, P. E., Racke, M., Slone, A. L., Siegel, B. W., Foye, P. E., Cannon, K. et al.. (1993) 
Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.
Proc Natl Acad Sci U S A, 90: 3452-3456. [PMID:7682702]

Fargin, A., Raymond, J. R., Regan, J. W., Cotecchia, S., Lefkowitz, R. J. and Caron, M. G. (1989) 
Effector coupling mechanisms of the cloned 5-HT1A receptor.
J Biol Chem, 264: 14848-14852. [PMID:2549039]

Fedouloff, M., Hossner, F., Voyle, M., Ranson, J., Powles, J., Riley, G. and Sanger, G. (2001) 
Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
Bioorg Med Chem, 9: 2119-2128. [PMID:11504648]

Fiorica-Howells, E., Hen, R., Gingrich, J., Li, Z. and Gershon, M. D. (2002) 
5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice.
Am J Physiol Gastrointest Liver Physiol, 282: G877-G893. [PMID:11960784]

Fitzgerald, L. W., Conklin, D. S., Krause, C. M., Marshall, A. P., Patterson, J. P., Tran, D. P., Iyer, G., Kostich, W. A., Largent, B. L. and Hartig, P. R. (1999) 
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
J Neurochem, 72: 2127-2134. [PMID:10217294]

Fitzgerald, L. W., Iyer, G., Conklin, D. S., Krause, C. M., Marshall, A., Patterson, J. P., Tran, D. P., Jonak, G. J. and Hartig, P. R. (1999) 
Messenger RNA editing of the human serotonin 5-HT2C receptor.
Neuropsychopharmacology, 21: 82S-90S. [PMID:10432493]

Foguet, M., Nguyen, H., Le, H. and Lubbert, H. (1992) 
Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes.
Neuroreport, 3: 345-348. [PMID:1381232]

Fone, K. C., Austin, R. H., Topham, I. A., Kennett, G. A. and Punhani, T. (1998) 
Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
Br J Pharmacol, 123: 1707-1715. [PMID:9605579]

Fonseca, M. I., Ni, Y. G., Dunning, D. D. and Miledi, R. (2001) 
Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata.
Brain Res Mol Brain Res, 89: 11-19. [PMID:11311971]

Forbes, IT; Douglas, S; Gribble, AD; Ife, RJ; Lightfoot, AP; Garner, AE; Riley, GJ; Jeffrey, P; Stevens, AJ; Stean, TO; et al.. (2002) 
SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.
Bioorg. Med. Chem. Lett., 12 (22): 3341-4. [PMID:12392747]

Ford, A. P., Baxter, G. S., Eglen, R. M. and Clarke, D. E. (1992) 
5-Hydroxytryptamine stimulates cyclic AMP formation in the tunica muscularis mucosae of the rat oesophagus via 5-HT4 receptors.
Eur J Pharmacol., 211: 117-120. [PMID:1319906]

Foxx-Orenstein, A. E., Kuemmerle, J. F. and Grider, J. R. (1996) 
Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine.
Gastroenterology, 111: 1281-1290. [PMID:8898642]

Francken, B. J., Jurzak, M., Vanhauwe, J. F., Luyten, W. H. and Leysen, J. E. (1998) 
The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells.
Eur J Pharmacol, 361: 299-309. [PMID:9865521]

Frank, M. G., Stryker, M. P. and Tecott, L. H. (2002) 
Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor.
Neuropsychopharmacology, 27: 869-873. [PMID:12431861]

Freire-Garabal, M., Nunez, M. J., Balboa, J., Lopez-Delgado, P., Gallego, R., Garcia-Caballero, T., Fernandez-Roel, M. D., Brenlla, J. and Rey-Mendez, M. (2003) 
Serotonin upregulates the activity of phagocytosis through 5-HT1A receptors.
Br J Pharmacol, 139: 457-463. [PMID:12770951]

Fujiwara, Y., Nelson, D. L., Kashihara, K., Varga, E., Roeske, W. R. and Yamamura, H. I. (1990) 
The cloning and sequence analysis of the rat serotonin-1A receptor gene.
Life Sci, 47: 127-132. [PMID:2273937]

Gaietta, G. M., Yoder, E. J., Deerinck, T., Kinder, K., Hanono, A., Han, A., Wu, C. and Ellisman, M. H. (2003) 
5-HT2a receptors in rat sciatic nerves and Schwann cell cultures.
J Neurocytol, 32: 373-380. [PMID:14724380]

Galeotti, N., Ghelardini, C. and Bartolini, A. (1998) 
Role of 5-HT4 receptors in the mouse passive avoidance test.
J Pharmacol Exp Ther, 286: 1115-1121. [PMID:9732367]

Garlow, S. J., Chin, A. C., Marinovich, A. M., Heller, M. R. and Ciaranello, R. D. (1994) 
Cloning and functional promoter mapping of the rat serotonin-2 receptor gene.
Mol Cell Neurosci, 5: 291-300. [PMID:8087427]

Garnovskaya, M. N., Gettys, T. W., van Biesen, T., Prpic, V., Chuprun, J. K. and Raymond, J. R. (1997) 
5-HT1A receptor activates Na+/H+ exchange in CHO-K1 cells through Gialpha2 and Gialpha3.
J Biol Chem, 272: 7770-7776. [PMID:9065439]

Garnovskaya, M. N., Nebigil, C. G., Arthur, J. M., Spurney, R. F. and Raymond, J. R. (1995) 
5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
Mol Pharmacol, 48: 230-237. [PMID:7651356]

Gaster, L. M., Blaney, F. E., Davies, S., Duckworth, D. M., Ham, P., Jenkins, S., Jennings, A. J., Joiner, G. F., King, F. D., Mulholland, K. R., Wyman, P. A., Hagan, J. J., Hatcher, J., Jones, B. J., Middlemiss, D. N., Price, G. W., Riley, G., Roberts, C., Routledge, C., Selkirk, J. and Slade, P. D. (1998) 
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
J Med Chem, 41: 1218-1235. [PMID:9548813]

Gerald, C., Adham, N., Kao, H. T., Olsen, M. A., Laz, T. M., Schechter, L. E., Bard, J. A., Vaysse, P. J., Hartig, P. R., Branchek, T. A. et al.. (1995) 
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.
EMBO J., 14: 2806-2815. [PMID:7796807]

Gibson, E. L., Barnfield, A. M. and Curzon, G. (1994) 
Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.
Neuropharmacology, 33: 457-465. [PMID:7984284]

Glennon, R. A., Lee, M., Rangisetty, J. B., Dukat, M., Roth, B. L., Savage, J. E., McBride, A., Rauser, L., Hufeisen, S. and Lee, D. K. (2000) 
2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
J Med Chem, 43: 1011-1018. [PMID:10715164]

Grailhe, R., Grabtree, G. W. and Hen, R. (2001) 
Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution.
Eur J Pharmacol, 418: 157-167. [PMID:11343685]

Grailhe, R., Waeber, C., Dulawa, S. C., Hornung, J. P., Zhuang, X., Brunner, D., Geyer, M. A. and Hen, R. (1999) 
Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor.
Neuron, 22: 581-591. [PMID:10197537]

Granas, C. and Larhammar, D. (1999) 
Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor.
Eur J Pharmacol, 380: 171-181. [PMID:10513577]

Grider, J. R. (2003) 
Neurotransmitters mediating the intestinal peristaltic reflex in the mouse.
J Pharmacol Exp Ther, 307: 460-467. [PMID:12966154]

Guptan, P., Dhingra, A. and Panicker, M. M. (1997) 
Multiple transcripts encode the 5-HT1F receptor in rodent brain.
Neuroreport, 8: 3317-3321. [PMID:9351664]

Guscott, M. R., Egan, E., Cook, G. P., Stanton, J. A., Beer, M. S., Rosahl, T. W., Hartmann, S., Kulagowski, J., McAllister, G., Fone, K. C. and Hutson, P. H. (2003) 
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor.
Neuropharmacology, 44: 1031-1037. [PMID:12763096]

Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F., Owens, A. P., Huscroft, I., Myers, J., Rupniak, N. M., Patel, S., Whiting, P. J., Hutson, P. H., Fone, K. C., Biello, S. M., Kulagowski, J. J. and McAllister, G. (2005) 
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.
Neuropharmacology, 48: 492-502. [PMID:15755477]

Hamada, S., Senzaki, K., Hamaguchi-Hamada, K., Tabuchi, K., Yamamoto, H., Yamamoto, T., Yoshikawa, S., Okano, H. and Okado, N. (1998) 
Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken.
Brain Res Mol Brain Res, 54: 199-211. [PMID:9555012]

Hamblin, M. W. and Metcalf, M. A. (1991) 
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Mol Pharmacol, 40: 143-148. [PMID:1652050]

Hamblin, M. W., McGuffin, R. W., Metcalf, M. A., Dorsa, D. M. and Merchant, K. M. (1992) 
Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors.
Mol. Cell. Neurosci., 3: 578-587.

Hamblin, M. W., Metcalf, M. A., McGuffin, R. W. and Karpells, S. (1992) 
Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity.
Biochem Biophys Res Commun, 184: 752-759. [PMID:1315531]

Hameg, A., Bayle, F., Nuss, P., Dupuis, P., Garay, R. P. and Dib, M. (2003) 
Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.
Biochem Pharmacol, 65: 435-440. [PMID:12527336]

Harada, K; Aota, M; Inoue, T; Matsuda, R; Mihara, T; Yamaji, T; Ishibashi, K; Matsuoka, N. (2006) 
Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Eur. J. Pharmacol., 553 (1-3): 171-84. [PMID:17074317]

Harte, S. E., Kender, R. G. and Borszcz, G. S. (2005) 
Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation.
Pain, 113: 405-415. [PMID:15661450]

Hasegawa, Y., Higuchi, S., Matsushita, S. and Miyaoka, H. (2002) 
Association of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2.
J Neural Transm, 109: 513-521. [PMID:11956970]

Hawi, Z., Dring, M., Kirley, A., Foley, D., Kent, L., Craddock, N., Asherson, P., Curran, S., Gould, A., Richards, S., Lawson, D., Pay, H., Turic, D., Langley, K., Owen, M., O'Donovan, M., Thapar, A., Fitzgerald, M. and Gill, M. (2002) 
Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample.
Mol Psychiatry, 7: 718-725. [PMID:12192616]

Hedlund, P. B., Carson, M. J., Sutcliffe, J. G. and Thomas, E. A. (1999) 
Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors.
Biochem Pharmacol, 58: 1807-1813. [PMID:10571256]

Hedlund, P. B., Kelly, L., Mazur, C., Lovenberg, T., Sutcliffe, J. G. and Bonaventure, P. (2004) 
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
Eur J Pharmacol, 487: 125-132. [PMID:15033384]

Hegde, S. S., Wong, A. G., Perry, M. R., Ku, P., Moy, T. M., Loeb, M. and Eglen, R. M. (1995) 
5-HT4 receptor mediated stimulation of gastric emptying in rats.
Naunyn Schmiedebergs Arch Pharmacol, 351: 589-595. [PMID:7675116]

Hegde, SS; Eglen, RM. (1996) 
Peripheral 5-HT4 receptors.
FASEB J., 10 (12): 1398-407. [PMID:8903510]

Heidmann, D. E., Szot, P., Kohen, R. and Hamblin, M. W. (1998) 
Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing.
Neuropharmacology, 37: 1621-1632. [PMID:9886685]

Heisler, L. K., Chu, H. M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H. and Tecott, L. H. (1998) 
Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.
Proc Natl Acad Sci U S A, 95: 15049-15054. [PMID:9844013]

Herrick-Davis, K., Egan, C. and Teitler, M. (1997) 
Activating mutations of the serotonin 5-HT2C receptor.
J Neurochem, 69: 1138-1144. [PMID:9282936]

Herrick-Davis, K., Grinde, E. and Niswender, C. M. (1999) 
Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
J Neurochem, 73: 1711-1717. [PMID:10501219]

Herrick-Davis, K., Grinde, E. and Teitler, M. (2000) 
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
J Pharmacol Exp Ther, 295: 226-232. [PMID:10991983]

Heusler, P; Palmier, C; Tardif, S; Bernois, S; Colpaert, FC; Cussac, D. (2010) 
[(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.
Naunyn Schmiedebergs Arch. Pharmacol., 382 (4): 321-30. [PMID:20799027]

Hirst, WD; Stean, TO; Rogers, DC; Sunter, D; Pugh, P; Moss, SF; Bromidge, SM; Riley, G; Smith, DR; Bartlett, S; et al.. (2006) 
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
Eur. J. Pharmacol., 553 (1-3): 109-19. [PMID:17069795]

Holenz, J; Mercè, R; Díaz, JL; Guitart, X; Codony, X; Dordal, A; Romero, G; Torrens, A; Mas, J; Andaluz, B; et al.. (2005) 
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
J. Med. Chem., 48 (6): 1781-95. [PMID:15771424]

Hou, M., Kanje, M., Longmore, J., Tajti, J., Uddman, R. and Edvinsson, L. (2001) 
5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase.
Brain Res, 909: 112-120. [PMID:11478927]

Hoyer, D; Hannon, JP; Martin, GR. (2002) 
Molecular, pharmacological and functional diversity of 5-HT receptors.
Pharmacol. Biochem. Behav., 71 (4): 533-54. [PMID:11888546]

Huang, Y. Y., Oquendo, M. A., Friedman, J. M., Greenhill, L. L., Brodsky, B., Malone, K. M., Khait, V. and Mann, J. J. (2003) 
Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism.
Neuropsychopharmacology, 28: 163-169. [PMID:12496953]

Hurley, P. T., McMahon, R. A., Fanning, P., O'Boyle, K. M., Rogers, M. and Martin, F. (1998) 
Functional coupling of a recombinant human 5-HT5A receptor to G-proteins in HEK-293 cells.
Br J Pharmacol, 124: 1238-1244. [PMID:9720796]

Jasper, J. R., Kosaka, A., To, Z. P., Chang, D. J. and Eglen, R. M. (1997) 
Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Br J Pharmacol, 122: 126-132. [PMID:9298538]

Jerning, E., Svantesson, G. T. and Mohell, N. (1998) 
Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
Eur J Pharmacol, 360: 219-225. [PMID:9851589]

Jin, H., Oksenberg, D., Ashkenazi, A., Peroutka, S. J., Duncan, A. M., Rozmahel, R., Yang, Y., Mengod, G., Palacios, J. M. and O'Dowd, B. F. (1992) 
Characterization of the human 5-hydroxytryptamine1B receptor.
J Biol Chem, 267: 5735-5738. [PMID:1348246]

Johansson, L., Sohn, D., Thorberg, S. O., Jackson, D. M., Kelder, D., Larsson, L. G., Renyi, L., Ross, S. B., Wallsten, C., Eriksson, H., Hu, P. S., Jerning, E., Mohell, N. and Westlind-Danielsson, A. (1997) 
The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
J Pharmacol Exp Ther, 283: 216-225. [PMID:9336327]

John, G. W., Pauwels, P. J., Perez, M., Halazy, S., Le Grand, B., Verscheure, Y., Valentin, J. P., Palmier, C., Wurch, T., Chopin, P., Marien, M., Kleven, M. S., Koek, W., Assie, M. B., Carilla-Durand, E., Tarayre, J. P. and Colpaert, F. C. (1999) 
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
J Pharmacol Exp Ther, 290: 83-95. [PMID:10381763]

Johnson, M. P., Loncharich, R. J., Baez, M. and Nelson, D. L. (1994) 
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
Mol Pharmacol, 45: 277-286. [PMID:8114677]

Johnson, S. W., Mercuri, N. B. and North, R. A. (1992) 
5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons.
J Neurosci, 12: 2000-2006. [PMID:1578282]

Jorand-Lebrun, C., Pauwels, P. J., Palmier, C., Moret, C., Chopin, P., Perez, M., Marien, M. and Halazy, S. (1997) 
5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine.
J Med Chem, 40: 3974-3978. [PMID:9397179]

Joubert, L., Claeysen, S., Sebben, M., Bessis, A. S., Clark, R. D., Martin, R. S., Bockaert, J. and Dumuis, A. (2002) 
A 5-HT4 receptor transmembrane network implicated in the activity of inverse agonists but not agonists.
J Biol Chem, 277: 25502-25501. [PMID:11976337]

Kadowaki, M., Wang, X. O., Shimatani, H., Yoneda, S. and Takaki, M. (2002) 
5-HT4 receptor enhances the propulsive power of the peristaltic reflex in the rat distal colon.
Auton Neurosci, 99: 62-65. [PMID:12171259]

Kalipatnapu, S., Pucadyil, T. J., Harikumar, K. G. and Chattopadhyay, A. (2004) 
Ligand binding characteristics of the human serotonin1A receptor heterologously expressed in CHO cells.
Biosci Rep, 24: 101-115. [PMID:15628665]

Kalkman, H. O., Subramanian, N. and Hoyer, D. (2001) 
Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
Neuropsychopharmacology, 25: 904-914. [PMID:11750183]

Kaumann, A. J. and Sanders, L. (1994) 
5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic beta-adrenoceptor blockade.
Naunyn Schmiedebergs Arch Pharmacol, 349: 331-337. [PMID:7914677]

Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J. and Brown, M. J. (1990) 
A 5-hydroxytryptamine receptor in human atrium.
Br J Pharmacol., 100: 879-885. [PMID:2169944]

Kawano, H., Tsuji, H., Nishimura, H., Kimura, S., Yano, S., Ukimura, N., Kunieda, Y., Yoshizumi, M., Sugano, T., Nakagawa, K., Masuda, H., Sawada, S. and Nakagawa, M. (2001) 
Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells.
Blood, 97: 1697-1702. [PMID:11238110]

Kaya, N., Shen, T., Lu, S. G., Zhao, F. L. and Herness, S. (2004) 
A paracrine signaling role for serotonin in rat taste buds: expression and localization of serotonin receptor subtypes.
Am J Physiol Regul Integr Comp Physiol, 286: R649-R658. [PMID:14715493]

Kellett, D. O., Ramage, A. G. and Jordan, D. (2005) 
Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats.
J Physiol, 563: 319-331. [PMID:15611034]

Kemp, A. and Manahan-Vaughan, D. (2005) 
The 5-hydroxytryptamine4 receptor exhibits frequency-dependent properties in synaptic plasticity and behavioural metaplasticity in the hippocampal CA1 region in vivo.
Cereb Cortex, 15: 1037-1043. [PMID:15537670]

Kennett, G. A., Wood, M. D., Bright, F., Cilia, J., Piper, D. C., Gager, T., Thomas, D., Baxter, G. S., Forbes, I. T., Ham, P. and Blackburn, T. P. (1996) 
In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.
Br J Pharmacol, 117: 427-434. [PMID:8821530]

Kennett, G. A., Wood, M. D., Bright, F., Trail, B., Riley, G., Holland, V., Avenell, K. Y., Stean, T., Upton, N., Bromidge, S., Forbes, I. T., Brown, A. M., Middlemiss, D. N. and Blackburn, T. P. (1997) 
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
Neuropharmacology, 36: 609-620. [PMID:9225286]

Khawaja, X., Ennis, C. and Minchin, M. C. (1997) 
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Life Sci, 60: 653-665. [PMID:9048968]

Kimura, Y., Hatanaka, K., Naitou, Y., Maeno, K., Shimada, I., Koakutsu, A., Wanibuchi, F. and Yamaguchi, T. (2004) 
Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
Eur J Pharmacol, 483: 37-43. [PMID:14709324]

Knight, A. R., Misra, A., Quirk, K., Benwell, K., Revell, D., Kennett, G. and Bickerdike, M. (2004) 
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Naunyn Schmiedebergs Arch Pharmacol, 370: 114-123. [PMID:15322733]

Koe, BK; Nielsen, JA; Macor, JE; Heym J. (1992) 
Biochemical and behavioural studies of the 5-HT_1B receptor agonist, CP-94,253.
Drug Development Research, 26: 241-250.

Kohen, R., Fashingbauer, L. A., Heidmann, D. E., Guthrie, C. R. and Hamblin, M. W. (2001) 
Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop.
Brain Res Mol Brain Res, 90: 110-117. [PMID:11406289]

Kohen, R., Metcalf, M. A., Khan, N., Druck, T., Huebner, K., Lachowicz, J. E., Meltzer, H. Y., Sibley, D. R., Roth, B. L. and Hamblin, M. W. (1996) 
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
J Neurochem, 66: 47-56. [PMID:8522988]

Kongsamut, S., Kang, J., Chen, X. L., Roehr, J. and Rampe, D. (2002) 
A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
Eur J Pharmacol, 450: 37-41. [PMID:12176106]

Kongsamut, S., Roehr, J. E., Cai, J., Hartman, H. B., Weissensee, P., Kerman, L. L., Tang, L. and Sandrasagra, A. (1996) 
Iloperidone binding to human and rat dopamine and 5-HT receptors.
Eur J Pharmacol, 317: 417-423. [PMID:8997630]

Kovacs, A., Gacsalyi, I., Wellmann, J., Schmidt, E., Szucs, Z., Dubreuil, V., Nicolas, J. P., Boutin, J., Bozsing, D., Egyed, A., Tihanyi, K., Spedding, M. and Szenasi, G. (2003) 
Effects of EGIS-7625, a selective and competitive 5-HT2B receptor antagonist.
Cardiovasc Drugs Ther, 17: 427-434. [PMID:15107597]

Krobert, K. A. and Levy, F. O. (2002) 
The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
Br J Pharmacol, 135: 1563-1571. [PMID:11906971]

Krobert, K. A., Bach, T., Syversveen, T., Kvingedal, A. M. and Levy, F. O. (2001) 
The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Naunyn Schmiedebergs Arch Pharmacol, 363: 620-632. [PMID:11414657]

Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y. and Roth, B. L. (2003) 
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Neuropsychopharmacology, 28: 519-526. [PMID:12629531]

Kulla, A. and Manahan-Vaughan, D. (2002) 
Modulation by serotonin 5-HT(4) receptors of long-term potentiation and depotentiation in the dentate gyrus of freely moving rats.
Cereb Cortex, 12: 150-162. [PMID:11739263]

Kursar, J. D., Nelson, D. L., Wainscott, D. B. and Baez, M. (1994) 
Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
Mol Pharmacol, 46: 227-234. [PMID:8078486]

Kursar, J. D., Nelson, D. L., Wainscott, D. B., Cohen, M. L. and Baez, M. (1992) 
Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.
Mol Pharmacol, 42: 549-557. [PMID:1331748]

Kusserow, H., Davies, B., Hortnagl, H., Voigt, I., Stroh, T., Bert, B., Deng, D. R., Fink, H., Veh, R. W. and Theuring, F. (2004) 
Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors.
Brain Res Mol Brain Res, 129: 104-116. [PMID:15469887]

Lacroix, L. P., Dawson, L. A., Hagan, J. J. and Heidbreder, C. A. (2004) 
5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex.
Synapse, 51: 258-264. [PMID:14618683]

Lam, S., Shen, Y., Nguyen, T., Messier, T. L., Brann, M., Comings, D., George, S. R. and O'Dowd, B. F. (1996) 
A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient.
Biochem Biophys Res Commun, 219: 853-858. [PMID:8645269]

Langlois, M. and Fischmeister, R. (2003) 
5-HT4 receptor ligands: applications and new prospects.
J Med Chem., 46: 319-344. [PMID:12540230]

Laporte, A. M., Doyen, C., Nevo, I. T., Chauveau, J., Hauw, J. J. and Hamon, M. (1996) 
Autoradiographic mapping of serotonin 5-HT1A, 5-HT1D, 5-HT2A and 5-HT3 receptors in the aged human spinal cord.
J Chem Neuroanat, 11: 67-75. [PMID:8841890]

Launay, J. M., Birraux, G., Bondoux, D., Callebert, J., Choi, D. S., Loric, S. and Maroteaux, L. (1996) 
Ras involvement in signal transduction by the serotonin 5-HT2B receptor.
J Biol Chem, 271: 3141-3147. [PMID:8621713]

Law, H., Dukat, M., Teitler, M., Lee, D. K., Mazzocco, L., Kamboj, R., Rampersad, V., Prisinzano, T. and Glennon, R. A. (1998) 
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
J Med Chem, 41: 2243-2251. [PMID:9632357]

Lawler, C. P., Prioleau, C., Lewis, M. M., Mak, C., Jiang, D., Schetz, J. A., Gonzalez, A. M., Sibley, D. R. and Mailman, R. B. (1999) 
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
Neuropsychopharmacology, 20: 612-627. [PMID:10327430]

Le Coniat, M., Choi, D. S., Maroteaux, L., Launay, J. M. and Berger, R. (1996) 
The 5-HT2B receptor gene maps to 2q36.3-2q37.1.
Genomics, 32: 172-173. [PMID:8786115]

Lee, M. D., Kennett, G. A., Dourish, C. T. and Clifton, P. G. (2002) 
5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253.
Psychopharmacology (Berl), 164: 49-60. [PMID:12373419]

Lefebvre, H., Gonzalez, K. N., Contesse, V., Delarue, C., Vaudry, H. and Kuhnl, J. M. (1998) 
Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers.
Endocr Res., 24: 749-752. [PMID:9888571]

Lejeune, F., Newman-Tancredi, A., Audinot, V. and Millan, M. J. (1997) 
Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
J Pharmacol Exp Ther, 280: 1241-1249. [PMID:9067310]

Leonardi, A., Guarneri, L., Poggesi, E., Angelico, P., Velasco, C., Cilia, A. and Testa, R. (2001) 
N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
J Pharmacol Exp Ther, 299: 1027-1037. [PMID:11714892]

Lesage, A. S., Wouters, R., Van Gompel, P., Heylen, L., Vanhoenacker, P., Haegeman, G., Luyten, W. H. and Leysen, J. E. (1998) 
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Br J Pharmacol, 123: 1655-1665. [PMID:9605573]

Levy, F. O., Holtgreve-Grez, H., Tasken, K., Solberg, R., Ried, T. and Gudermann, T. (1994) 
Assignment of the gene encoding the 5-HT1E serotonin receptor (S31) (locus HTR1E) to human chromosome 6q14-q15.
Genomics, 22: 637-640. [PMID:8001977]

Leysen, J. E., Gommeren, W., Heylen, L., Luyten, W. H., Van de Weyer, I., Vanhoenacker, P., Haegeman, G., Schotte, A., Van Gompel, P., Wouters, R. and Lesage, A. S. (1996) 
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Mol Pharmacol, 50: 1567-1580. [PMID:8967979]

Li, N., Wallen, N. H., Ladjevardi, M. and Hjemdahl, P. (1997) 
Effects of serotonin on platelet activation in whole blood.
Blood Coagul Fibrinolysis, 8: 517-523. [PMID:9491270]

Li, Q., Holmes, A., Ma, L., Van de Kar, L. D., Garcia, F. and Murphy, D. L. (2004) 
Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences.
J Neurosci, 24: 10868-10877. [PMID:15574737]

Lin, S. L., Setya, S., Johnson-Farley, N. N. and Cowen, D. S. (2002) 
Differential coupling of 5-HT(1) receptors to G proteins of the G(i) family.
Br J Pharmacol, 136: 1072-1078. [PMID:12145108]

Liu, M., Geddis, M. S., Wen, Y., Setlik, W. and Gershon, M. D. (2005) 
Expression and function of 5-HT4 receptors in the mouse enteric nervous system.
Am J Physiol Gastrointest Liver Physiol, 289: G1148-G1163. [PMID:16037544]

Lopez-Gimenez, J. F., Villazon, M., Brea, J., Loza, M. I., Palacios, J. M., Mengod, G. and Vilaro, M. T. (2001) 
Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
Mol Pharmacol, 60: 690-699. [PMID:11562430]

Lopez-Meraz, M. L., Gonzalez-Trujano, M. E., Neri-Bazan, L., Hong, E. and Rocha, L. L. (2005) 
5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats.
Neuropharmacology, 49: 367-375. [PMID:15993434]

Loric, S., Launay, J. M., Colas, J. F. and Maroteaux, L. (1992) 
New mouse 5-HT2-like receptor. Expression in brain, heart and intestine.
FEBS Lett, 312: 203-207. [PMID:1426253]

Loric, S., Maroteaux, L., Kellermann, O. and Launay, J. M. (1995) 
Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.
Mol Pharmacol, 47: 458-466. [PMID:7700243]

Lovenberg, T. W., Baron, B. M., De Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., Foye, P. E., Racke, M., Slone, A. L., Siegel, B. W. et al.. (1993) 
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.
Neuron, 11: 449-458. [PMID:8398139]

Lovenberg, T. W., Erlander, M. G., Baron, B. M., Racke, M., Slone, A. L., Siegel, B. W., Craft, C. M., Burns, J. E., Danielson, P. E. and Sutcliffe, J. G. (1993) 
Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.
Proc Natl Acad Sci U S A, 90: 2184-2188. [PMID:8384716]

Lucaites, V. L., Nelson, D. L., Wainscott, D. B. and Baez, M. (1996) 
Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily.
Life Sci, 59: 1081-1095. [PMID:8809227]

Lucas, J. J., Segu, L. and Hen, R. (1997) 
5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935.
Mol Pharmacol, 51: 755-763. [PMID:9145913]

Ma, Q. P. (2001) 
Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats.
Neuroreport, 12: 1589-1591. [PMID:11409721]

Madjid, N., Elvander Tottie, E., Luttgen, M., Meister, B., Sandin, J., Kuzmin, A., Stiedl, O. and Ogren, S. O. (2005) 
5-HT1A Receptor Blockade Facilitates Aversive Learning in Mice: Interactions with Cholinergic and Glutamatergic Mechanisms.
J Pharmacol Exp Ther, : -. [PMID:16223872]

Madsen, K; Marner, L; Haahr, M; Gillings, N; Knudsen, GM. (2011) 
Mass dose effects and in vivo affinity in brain PET receptor studies--a study of cerebral 5-HT4 receptor binding with [11C]SB207145.
Nucl. Med. Biol., 38 (8): 1085-91. [PMID:21831646]

Maier, DL; Sobotka-Briner, C; Ding, M; Powell, ME; Jiang, Q; Hill, G; Heys, JR; Elmore, CS; Pierson, ME; Mrzljak, L. (2009) 
[N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
J. Pharmacol. Exp. Ther., 330 (1): 342-51. [PMID:19401496]

Maillet, M., Robert, S. J., Cacquevel, M., Gastineau, M., Vivien, D., Bertoglio, J., Zugaza, J. L., Fischmeister, R. and Lezoualc'h, F. (2003) 
Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha.
Nat Cell Biol., 5: 633-639. [PMID:12819788]

Makarenko, I. G., Meguid, M. M. and Ugrumov, M. V. (2000) 
Distribution of serotonin 5-hydroxytriptamine 1B (5-HT(1B)) receptors in the normal rat hypothalamus.
Neurosci Lett., 328: 155-159. [PMID:12133578]

Malgouris, C; Flamand, F; Doble, A. (1993) 
Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain.
Eur. J. Pharmacol., 233 (1): 37-45. [PMID:8472747]

Manrique, C., Hery, F., Faudon, M. and Francois-Bellan, A. M. (1999) 
Indirect evidence for an association of 5-HT(1B) binding sites with retinal and geniculate axon terminals in the rat suprachiasmatic nucleus.
Synapse, 33: 314-323. [PMID:10421712]

Manzke, T., Guenther, U., Ponimaskin, E. G., Haller, M., Dutschmann, M., Schwarzacher, S. and Richter, D. W. (2003) 
5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia.
Science., 301: 226-229. [PMID:12855812]

Marazziti, D., Ori, M., Nardini, M., Rossi, A., Nardi, I. and Cassano, G. B. (2001) 
mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes.
Neuropsychobiology, 43: 123-126. [PMID:11287788]

Marchetti, E., Dumuis, A., Bockaert, J., Soumireu-Mourat, B. and Roman, F. S. (2000) 
Differential modulation of the 5-HT(4) receptor agonists and antagonist on rat learning and memory.
Neuropharmacology, 39: 2017-2027. [PMID:10963745]

Markstein, R., Matsumoto, M., Kohler, C., Togashi, H., Yoshioka, M. and Hoyer, D. (1999) 
Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus.
Naunyn Schmiedebergs Arch Pharmacol, 359: 454-459. [PMID:10431755]

Maroteaux, L., Saudou, F., Amlaiky, N., Boschert, U., Plassat, J. L. and Hen, R. (1992) 
Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers.
Proc Natl Acad Sci U S A, 89: 3020-3024. [PMID:1557407]

Matthes, H., Boschert, U., Amlaiky, N., Grailhe, R., Plassat, J. L., Muscatelli, F., Mattei, M. G. and Hen, R. (1993) 
Mouse 5-hydroxytryptamine 5A and 5-hydroxytryptamine 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
Mol. Pharmacol., 43: 313-319. [PMID:8450829]

Maura, G. and Raiteri, M. (1986) 
Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release.
Eur J Pharmacol, 129: 333-337. [PMID:3780847]

May, J. A., Chen, H. H., Rusinko, A., Lynch, V. M., Sharif, N. A. and McLaughlin, M. A. (2003) 
A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
J Med Chem, 46: 4188-4195. [PMID:12954071]

McAllister, G., Charlesworth, A., Snodin, C., Beer, M. S., Noble, A. J., Middlemiss, D. N., Iversen, L. L. and Whiting, P. (1992) 
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype.
Proc Natl Acad Sci U S A, 89: 5517-5521. [PMID:1608964]

McCall, R. B., Romero, A. G., Bienkowski, M. J., Harris, D. W., McGuire, J. C., Piercey, M. F., Shuck, M. E., Smith, M. W., Svensson, K. A., Schreur, P. J. et al.. (1994) 
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
J Pharmacol Exp Ther, 271: 875-883. [PMID:7965808]

McLean, P. G. and Coupar, I. M. (1996) 
Stimulation of cyclic AMP formation in the circular smooth muscle of human colon by activation of 5-HT4-like receptors.
Br J Pharmacol, 117: 238-239. [PMID:8789374]

McLean, P. G. and Coupar, I. M. (1996) 
Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon.
Br J Pharmacol, 118: 1058-1064. [PMID:8799582]

Medhurst, A. D., Lezoualc'h, F., Fischmeister, R., Middlemiss, D. N. and Sanger, G. J. (2001) 
Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR.
Brain Res Mol Brain Res, 90: 125-134. [PMID:11406291]

Mialet, J., Berque-Bestel, I., Eftekhari, P., Gastineau, M., Giner, M., Dahmoune, Y., Donzeau-Gouge, P., Hoebeke, J., Langlois, M., Sicsic, S., Fischmeister, R. and Lezoualc'h, F. (2000) 
Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Br J Pharmacol, 129: 771-781. [PMID:10683202]

Mialet, J., Berque-Bestel, I., Sicsic, S., Langlois, M., Fischmeister, R. and Lezoualc'h, F. (2000) 
Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Br J Pharmacol, 131: 827-835. [PMID:11030734]

Mialet, J., Dahmoune, Y., Lezoualc'h, F., Berque-Bestel, I., Eftekhari, P., Hoebeke, J., Sicsic, S., Langlois, M. and Fischmeister, R. (2000) 
Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
Br J Pharmacol, 130: 527-538. [PMID:10821780]

Middlemiss, DN; Göthert, M; Schlicker, E; Scott, CM; Selkirk, JV; Watson, J; Gaster, LM; Wyman, P; Riley, G; Price, GW. (1999) 
SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
Eur. J. Pharmacol., 375 (1-3): 359-65. [PMID:10443589]

Mijnster, M. J., Raimundo, A. G., Koskuba, K., Klop, H., Docter, G. J., Groenewegen, H. J. and Voorn, P. (1997) 
Regional and cellular distribution of serotonin 5-hydroxytryptamine2a receptor mRNA in the nucleus accumbens, olfactory tubercle, and caudate putamen of the rat.
J Comp Neurol, 389: 1-11. [PMID:9390756]

Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J. M. and Cussac, D. (2003) 
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.
J Pharmacol Exp Ther, 306: 954-964. [PMID:12750432]

Millan, M. J., Gobert, A., Newman-Tancredi, A., Audinot, V., Lejeune, F., Rivet, J. M., Cussac, D., Nicolas, J. P., Muller, O. and Lavielle, G. (1998) 
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
J Pharmacol Exp Ther, 286: 1341-1355. [PMID:9732398]

Millan, M. J., Gobert, A., Newman-Tancredi, A., Lejeune, F., Cussac, D., Rivet, J. M., Audinot, V., Dubuffet, T. and Lavielle, G. (2000) 
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
J Pharmacol Exp Ther, 293: 1048-1062. [PMID:10869410]

Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J. A. and Newman-Tancredi, A. (2002) 
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
J Pharmacol Exp Ther, 303: 791-804. [PMID:12388666]

Millan, M. J., Newman-Tancredi, A., Audinot, V., Cussac, D., Lejeune, F., Nicolas, J. P., Cogé, F., Galizzi, J. P., Boutin, J. A., Rivet, J. M., Dekeyne, A. and Gobert, A. (2000) 
Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
Synapse, 35: 79-95. [PMID:10611634]

Miller, K. J. and Teitler, M. (1992) 
Quantitative autoradiography of 5-CT-sensitive (5-HT1D) and 5-CT-insensitive (5-HT1E) serotonin receptors in human brain.
Neurosci Lett, 136: 223-226. [PMID:1641195]

Mitsui, R., Ono, S., Karaki, S. and Kuwahara, A. (2005) 
Neural and non-neural mediation of propionate-induced contractile responses in the rat distal colon.
Neurogastroenterol Motil, 17: 585-594. [PMID:16078948]

Mlinar, B. and Corradetti, R. (2003) 
Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
Eur J Neurosci, 18: 1559-1571. [PMID:14511335]

Mochizuki, D., Yuyama, Y., Tsujita, R., Komaki, H. and Sagai, H. (1992) 
Cloning and expression of the human 5-HT1B-type receptor gene.
Biochem Biophys Res Commun, 185: 517-523. [PMID:1610347]

Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W. and Sibley, D. R. (1993) 
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Mol Pharmacol, 43: 320-327. [PMID:7680751]

Monti, J. M. and Jantos, H. (2003) 
Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
Eur J Pharmacol, 478: 121-130. [PMID:14575796]

Monti, J. M. and Jantos, H. (2004) 
Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
Behav Brain Res, 151: 159-166. [PMID:15084431]

Morikawa, H., Manzoni, O. J., Crabbe, J. C. and Williams, J. T. (2000) 
Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors.
Mol Pharmacol, 58: 1271-1278. [PMID:11093763]

Moser, P. C., Bergis, O. E., Jegham, S., Lochead, A., Duconseille, E., Terranova, J. P., Caille, D., Berque-Bestel, I., Lezoualc'h, F., Fischmeister, R., Dumuis, A., Bockaert, J., George, P., Soubrie, P. and Scatton, B. (2002) 
SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties.
J Pharmacol Exp Ther, 302: 731-741. [PMID:12130738]

Mota, A., Bento, A., Penalva, A., Pombo, M. and Dieguez, C. (1995) 
Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
J Clin Endocrinol Metab, 80: 1973-1977. [PMID:7775648]

Moummi, C., Yang, D. C. and Gullikson, G. W. (1992) 
5-HT4 receptor activation induces relaxation and associated cAMP generation in rat esophagus.
Eur J Pharmacol, 216: 47-52. [PMID:1326439]

Muraki, Y., Yamanaka, A., Tsujino, N., Kilduff, T. S., Goto, K. and Sakurai, T. (2004) 
Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.
J Neurosci, 24: 7159-7166. [PMID:15306649]

Nagakura, Y., Akuzawa, S., Miyata, K., Kamato, T., Suzuki, T., Ito, H. and Yamaguchi, T. (1999) 
Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
Pharmacol Res, 39: 375-382. [PMID:10328995]

Nagakura, Y., Ito, H., Kiso, T., Naitoh, Y. and Miyata, K. (1997) 
The selective 5-hydroxytryptamine (5-HT)4-receptor agonist RS67506 enhances lower intestinal propulsion in mice.
Jpn J Pharmacol, 74: 209-212. [PMID:9243330]

Nakhai, B., Nielsen, D. A., Linnoila, M. and Goldman, D. (1995) 
Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28.
Biochem Biophys Res Commun, 210: 530-536. [PMID:7755630]

Napier, C., Stewart, M., Melrose, H., Hopkins, B., McHarg, A. and Wallis, R. (1999) 
Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
Eur J Pharmacol, 368: 259-268. [PMID:10193663]

Nebigil, C. G., Choi, D. S., Dierich, A., Hickel, P., Le Meur, M., Messaddeq, N., Launay, J. M. and Maroteaux, L. (2000) 
Serotonin 2B receptor is required for heart development.
Proc Natl Acad Sci U S A, 97: 9508-9513. [PMID:10944220]

Nebigil, C. G., Hickel, P., Messaddeq, N., Vonesch, J. L., Douchet, M. P., Monassier, L., Gyorgy, K., Matz, R., Andriantsitohaina, R., Manivet, P., Launay, J. M. and Maroteaux, L. (2001) 
Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function.
Circulation, 103: 2973-2979. [PMID:11413089]

Nebigil, C. G., Jaffre, F., Messaddeq, N., Hickel, P., Monassier, L., Launay, J. M. and Maroteaux, L. (2003) 
Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.
Circulation, 107: 3223-3229. [PMID:12810613]

Nelson, D. L., Lucaites, V. L., Wainscott, D. B. and Glennon, R. A. (1999) 
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Naunyn Schmiedebergs Arch Pharmacol, 359: 1-6. [PMID:9933142]

Nelson, DL; Phebus, LA; Johnson, KW; Wainscott, DB; Cohen, ML; Calligaro, DO; Xu, YC. (2010) 
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan.
Cephalalgia, 30 (10): 1159-69. [PMID:20855361]

Newman-Tancredi, A., Audinot, V., Moreira, C., Verriele, L. and Millan, M. J. (2000) 
Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.
Mol Pharmacol, 58: 1042-1049. [PMID:11040052]

Newman-Tancredi, A., Conte, C., Chaput, C., Verriele, L., Audinot-Bouchez, V., Lochon, S., Lavielle, G. and Millan, M. J. (1997) 
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Naunyn Schmiedebergs Arch Pharmacol, 355: 682-688. [PMID:9205951]

Newman-Tancredi, A., Cussac, D., Audinot, V. and Millan, M. J. (1999) 
Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
Naunyn Schmiedebergs Arch Pharmacol, 359: 447-453. [PMID:10431754]

Newman-Tancredi, A., Gavaudan, S., Conte, C., Chaput, C., Touzard, M., Verriele, L., Audinot, V. and Millan, M. J. (1998) 
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Eur J Pharmacol, 355: 245-256. [PMID:9760039]

Newman-Tancredi, A., Verriele, L., Chaput, C. and Millan, M. J. (1998) 
Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Naunyn Schmiedebergs Arch Pharmacol, 357: 205-217. [PMID:9550290]

Newman-Tancredi, A., Wootton, R. and Strange, P. G. (1992) 
High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells.
Biochem J, 285: 933-938. [PMID:1386736]

Newman-Tancredi, A; Martel, JC; Assié, MB; Buritova, J; Lauressergues, E; Cosi, C; Heusler, P; Bruins Slot, L; Colpaert, FC; Vacher, B; et al.. (2009) 
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.
Br. J. Pharmacol., 156 (2): 338-53. [PMID:19154445]

Nichols, D. E., Frescas, S., Marona-Lewicka, D. and Kurrasch-Orbaugh, D. M. (2002) 
Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
J Med Chem, 45: 4344-4349. [PMID:12213075]

Nilsson, T., Longmore, J., Shaw, D., Olesen, I. J. and Edvinsson, L. (1999) 
Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Br J Pharmacol, 128: 1133-1140. [PMID:10578124]

Nilsson, T., Longmore, J., Shaw, D., Pantev, E., Bard, J. A., Branchek, T. and Edvinsson, L. (1999) 
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Eur J Pharmacol, 372: 49-56. [PMID:10374714]

Ning, Y., Zhu, J. X. and Chan, H. C. (2004) 
Regulation of ion transport by 5-hydroxytryptamine in rat colon.
Clin Exp Pharmacol Physiol, 31: 424-428. [PMID:15236628]

Niswender, C. M., Copeland, S. C., Herrick-Davis, K., Emeson, R. B. and Sanders-Bush, E. (1999) 
RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.
J Biol Chem, 274: 9472-9478. [PMID:10092629]

Noda, M., Higashida, H., Aoki, S. and Wada, K. (2004) 
Multiple signal transduction pathways mediated by 5-HT receptors.
Mol Neurobiol, 29: 31-39. [PMID:15034221]

Noda, M., Yasuda, S., Okada, M., Higashida, H., Shimada, A., Iwata, N., Ozaki, N., Nishikawa, K., Shirasawa, S., Uchida, M., Aoki, S. and Wada, K. (2003) 
Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways.
J Neurochem, 84: 222-232. [PMID:12558985]

Nonogaki, K., Abdallah, L., Goulding, E. H., Bonasera, S. J. and Tecott, L. H. (2003) 
Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice.
Diabetes, 52: 315-320. [PMID:12540602]

Nonogaki, K., Memon, R. A., Grunfeld, C., Feingold, K. R. and Tecott, L. H. (2002) 
Altered gene expressions involved in energy expenditure in 5-HT(2C) receptor mutant mice.
Biochem Biophys Res Commun, 295: 249-254. [PMID:12150939]

Norum, J. H., Hart, K. and Levy, F. O. (2003) 
Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a).
J Biol Chem, 278: 3098-3104. [PMID:12446729]

Okamoto, K., Imbe, H., Morikawa, Y., Itoh, M., Sekimoto, M., Nemoto, K. and Senba, E. (2002) 
5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats.
Pain, 99: 133-143. [PMID:12237191]

Olsen, M. A., Nawoschik, S. P., Schurman, B. R., Schmitt, H. L., Burno, M., Smith, D. L. and Schechter, L. E. (1999) 
Identification of a human 5-HT6 receptor variant produced by alternative splicing.
Brain Res Mol Brain Res, 64: 255-263. [PMID:9931499]

Ono, S., Mitsui, R., Karaki, S. and Kuwahara, A. (2005) 
Muscarinic and 5-HT4 receptors participate in the regulation of the frequency of spontaneous contractions of the longitudinal muscle in rat distal colon.
Biomed Res, 26: 173-177. [PMID:16152733]

Osei-Owusu, P., James, A., Crane, J. and Scrogin, K. E. (2005) 
5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome.
J Pharmacol Exp Ther, 313: 1324-1330. [PMID:15743927]

Ouadid, H., Seguin, J., Dumuis, A., Bockaert, J. and Nargeot, J. (1992) 
Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
Mol Pharmacol., 41: 346-351. [PMID:1311410]

Parker, E. M., Izzarelli, D. G., Lewis-Higgins, L., Palmer, D. and Shapiro, R. A. (1996) 
Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors.
J Neurochem, 67: 2096-2103. [PMID:8863519]

Parker, M. A., Marona-Lewicka, D., Lucaites, V. L., Nelson, D. L. and Nichols, D. E. (1998) 
A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.
J Med Chem, 41: 5148-5149. [PMID:9857084]

Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T. and Toth, M. (1998) 
Increased anxiety of mice lacking the serotonin1A receptor.
Proc Natl Acad Sci U S A, 95: 10734-10739. [PMID:9724773]

Pasqualetti, M., Ori, M., Nardi, I., Castagna, M., Cassano, G. B. and Marazziti, D. (1998) 
Distribution of the 5-HT5A serotonin receptor mRNA in the human brain.
Brain Res Mol Brain Res, 56: 1-8. [PMID:9602024]

Pattij, T., Broersen, L. M., van der Linde, J., Groenink, L., van der Gugten, J., Maes, R. A. and Olivier, B. (2003) 
Operant learning and differential-reinforcement-of-low-rate 36-s responding in 5-HT1A and 5-HT1B receptor knockout mice.
Behav Brain Res, 141: 137-145. [PMID:12742250]

Pauwels, P. J., Wurch, T., Amoureux, M. C., Palmier, C. and Colpaert, F. C. (1996) 
Stimulation of cloned human serotonin 5-HT1D beta receptor sites in stably transfected C6 glial cells promotes cell growth.
J Neurochem, 66: 65-73. [PMID:8522991]

Pazos, A., Hoyer, D. and Palacios, J. M. (1984) 
The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
Eur J Pharmacol, 106: 539-546. [PMID:6519175]

Perez-Garcia, G. and Meneses, A. (2005) 
Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task.
Pharmacol Biochem Behav, 81: 673-682. [PMID:15964617]

Perez-Garcia, G. S. and Meneses, A. (2005) 
Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task.
Behav Brain Res, 163: 136-140. [PMID:15936093]

Pesonen, U., Rouru, J., Huupponen, R. and Koulu, M. (1991) 
Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats.
Brain Res Mol Brain Res, 10: 267-272. [PMID:1653393]

Phebus, L. A., Johnson, K. W., Zgombick, J. M., Gilbert, P. J., Van Belle, K., Mancuso, V., Nelson, D. L., Calligaro, D. O., Kiefer, A. D., Branchek, T. A. and Flaugh, M. E. (1997) 
Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine.
Life Sci, 61: 2117-212. [PMID:9395253]

Pickard, G. E., Smith, B. N., Belenky, M., Rea, M. A., Dudek, F. E. and Sollars, P. J. (1999) 
5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus.
J Neurosci, 19: 4034-4045. [PMID:10234032]

Pierce, P. A., Xie, G. X., Levine, J. D. and Peroutka, S. J. (1996) 
5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study.
Neuroscience, 70: 553-559. [PMID:8848158]

Pierce, P. A., Xie, G. X., Peroutka, S. J., Green, P. G. and Levine, J. D. (1995) 
5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals.
J Pharmacol Exp Ther, 275: 502-508. [PMID:7562592]

Pindon, A., van Hecke, G., Van Gompel, P., Lesage, A. S., Leysen, J. E. and Jurzak, M. (2002) 
Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins.
Mol Pharmacol, 61: 85-96. [PMID:11752209]

Pineyro, G., de Montigny, C. and Blier, P. (1995) 
5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Neuropsychopharmacology, 13: 249-260. [PMID:8602897]

Plassat, J. L., Amlaiky, N. and Hen, R. (1993) 
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Mol Pharmacol, 44: 229-236. [PMID:8394987]

Pompeiano, M., Palacios, J. M. and Mengod, G. (1992) 
Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding.
J Neurosci, 12: 440-453. [PMID:1531498]

Pompeiano, M., Palacios, J. M. and Mengod, G. (1994) 
Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.
Brain Res Mol Brain Res, 23: 163-178. [PMID:8028479]

Ponimaskin, E. G., Profirovic, J., Vaiskunaite, R., Richter, D. W. and Voyno-Yasenetskaya, T. A. (2002) 
5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein.
J Biol Chem., 277: 20812-20819. [PMID:11923294]

Popova, N. K., Naumenko, V. S., Plyusnina, I. Z. and Kulikov, A. V. (2005) 
Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats.
J Neurosci Res, 80: 286-292. [PMID:15765530]

Porter, R. H., Benwell, K. R., Lamb, H., Malcolm, C. S., Allen, N. H., Revell, D. F., Adams, D. R. and Sheardown, M. J. (1999) 
Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
Br J Pharmacol, 128: 13-20. [PMID:10498829]

Potrebic, S., Ahn, A. H., Skinner, K., Fields, H. L. and Basbaum, A. I. (2003) 
Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans.
J Neurosci, 23: 10988-10997. [PMID:14645495]

Price, G. W., Burton, M. J., Collin, L. J., Duckworth, M., Gaster, L., Gothert, M., Jones, B. J., Roberts, C., Watson, J. M. and Middlemiss, D. N. (1997) 
SB-216641 and BRL-15572 compounds to pharmacologically discriminate h5-HT_1B and h5-HT_1D receptors.
Naunyn Schmiedebergs Arch. Pharmacol., 356: 312-320. [PMID:9303567]

Price, R. D., Weiner, D. M., Chang, M. S. and Sanders-Bush, E. (2001) 
RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein.
J Biol Chem, 276: 44663-44668. [PMID:11572865]

Purohit, A., Smith, C., Herrick-Davis, K. and Teitler, M. (2005) 
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.
Psychopharmacology (Berl), 179: 461-469. [PMID:15821958]

Pälvimäki, E. P., Roth, B. L., Majasuo, H., Laakso, A., Kuoppamäki, M., Syvälahti, E. and Hietala, J. (1996) 
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
Psychopharmacology (Berl), 126: 234-240. [PMID:8876023]

Quist, J. F., Barr, C. L., Schachar, R., Roberts, W., Malone, M., Tannock, R., Basile, V. S., Beitchman, J. and Kennedy, J. L. (2003) 
The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder.
Mol Psychiatry, 8: 98-102. [PMID:12556913]

Ramboz, S., Oosting, R., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M., Mann, J. J., Brunner, D. and Hen, R. (1998) 
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.
Proc Natl Acad Sci U S A, 95: 14476-14481. [PMID:9826725]

Ramirez, M. J., García-Garayoa, E., Romero, G., Monge, A., Roca, J., Del Río, J. and Lasheras, B. (1997) 
VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. I. Interaction with 5-HT3 and 5-HT4 receptors.
J Pharm Pharmacol, 49: 58-65. [PMID:9120772]

Rashid, M., Manivet, P., Nishio, H., Pratuangdejkul, J., Rajab, M., Ishiguro, M., Launay, J. M. and Nagatomo, T. (2003) 
Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
Life Sci, 73: 193-207. [PMID:12738034]

Rauser, L., Savage, J. E., Meltzer, H. Y. and Roth, B. L. (2001) 
Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
J Pharmacol Exp Ther, 299: 83-89. [PMID:11561066]

Raymond, J. R., Kim, J., Beach, R. E. and Tisher, C. C. (1993) 
Immunohistochemical mapping of cellular and subcellular distribution of 5-HT1A receptors in rat and human kidneys.
Am J Physiol, 264: 9-19. [PMID:8430834]

Reavill, C., Kettle, A., Holland, V., Riley, G. and Blackburn, T. P. (1999) 
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Br J Pharmacol, 126: 572-574. [PMID:10188965]

Reavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., Hadley, M. S., Hunter, A. J., Jeffrey, P., Jewitt, F., Johnson, C. N., Jones, D. N., Medhurst, A. D., Middlemiss, D. N., Nash, D. J., Riley, G. J., Routledge, C., Stemp, G., Thewlis, K. M., Trail, B., Vong, A. K. and Hagan, J. J. (2000) 
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
J Pharmacol Exp Ther, 294: 1154-1165. [PMID:10945872]

Rees, S., den Daas, I., Foord, S., Goodson, S., Bull, D., Kilpatrick, G. and Lee, M. (1994) 
Cloning and characterisation of the human 5-HT_5A serotonin receptor.
FEBS Lett., 355: 242-246. [PMID:7988681]

Reeves, J. J., Bunce, K. T. and Humphrey, P. P. (1991) 
Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus.
Br J Pharmacol., 103: 1067-1072. [PMID:1878746]

Reynolds, G. P., Mason, S. L., Meldrum, A., De Keczer, S., Parnes, H., Eglen, R. M. and Wong, E. H. (1995) 
5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
Br J Pharmacol, 114: 993-998. [PMID:7780656]

Rivail, L., Giner, M., Gastineau, M., Berthouze, M., Soulier, J. L., Fischmeister, R., Lezoualc'h, F., Maigret, B., Sicsic, S. and Berque-Bestel, I. (2004) 
New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.
Br J Pharmacol, 143: 361-370. [PMID:15351779]

Rocha-Gonzalez, H. I., Meneses, A., Carlton, S. M. and Granados-Soto, V. (2005) 
Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test.
Pain, 117: 182-192. [PMID:16098671]

Rogers, D. C. and Hagan, J. J. (2001) 
5-HT6 receptor antagonists enhance retention of a water maze task in the rat.
Psychopharmacology (Berl), 158: 114-119. [PMID:11702084]

Roth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., Monsma, F. J., Shen, Y., Meltzer, H. Y. and Sibley, D. R. (1994) 
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
J Pharmacol Exp Ther, 268: 1403-1410. [PMID:7908055]

Roth, B. L., Ernsberger, P., Steinberg, S. A., Rao, S., Rauser, L., Savage, J., Hufeisen, S., Berridge, M. S. and Muzic, R. F. (2001) 
The in vitro pharmacology of the beta-adrenergic receptor pet ligand (s)-fluorocarazolol reveals high affinity for cloned beta-adrenergic receptors and moderate affinity for the human 5-HT1A receptor.
Psychopharmacology (Berl), 157: 111-114. [PMID:11512051]

Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J. and Roth, B. L. (2000) 
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Circulation, 102: 2836-2841. [PMID:11104741]

Rousselle, J. C., Plantefol, M., Fillion, M. P., Massot, O., Pauwels, P. J. and Fillion, G. (1998) 
Specific interaction of 5-HT-moduline with human 5-HT1b as well as 5-HT1d receptors expressed in transfected cultured cells.
Naunyn Schmiedebergs Arch Pharmacol, 358: 279-286. [PMID:9774213]

Ruat, M., Traiffort, E., Arrang, J. M., Tardivel-Lacombe, J., Diaz, J., Leurs, R. and Schwartz, J. C. (1993) 
A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.
Biochem Biophys Res Commun, 193: 268-276. [PMID:8389146]

Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M. and Schwartz, J. C. (1993) 
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Proc Natl Acad Sci U S A, 90: 8547-8551. [PMID:8397408]

Russell, M. G., Matassa, V. G., Pengilley, R. R., van Niel, M. B., Sohal, B., Watt, A. P., Hitzel, L., Beer, M. S., Stanton, J. A., Broughton, H. B. and Castro, J. L. (1999) 
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
J Med Chem, 42: 4981-5001. [PMID:10585208]

Sakurai-Yamashita, Y., Takada, K., Takemura, K., Yamashita, K., Enjoji, A., Kanematsu, T. and Taniyama, K. (1999) 
Ability of mosapride to bind to 5-HT4 receptor in the human stomach.
Jpn J Pharmacol, 79: 493-496. [PMID:10361891]

Sakurai-Yamashita, Y., Yamashita, K., Kanematsu, T. and Taniyama, K. (1999) 
Localization of the 5-HT(4) receptor in the human and the guinea pig colon.
Eur J Pharmacol, 383: 281-285. [PMID:10594320]

Sakurai-Yamashita, Y., Yamashita, K., Yoshimura, M. and Taniyama, K. (2000) 
Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum.
Life Sci, 66: 31-34. [PMID:10658921]

Sari, Y., Miquel, M. C., Brisorgueil, M. J., Ruiz, G., Doucet, E., Hamon, M. and Verge, D. (1999) 
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies.
Neuroscience, 88: 899-915. [PMID:10363826]

Sarnyai, Z., Sibille, E. L., Pavlides, C., Fenster, R. J., McEwen, B. S. and Toth, M. (2000) 
Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors.
Proc Natl Acad Sci U S A, 97: 14731-14736. [PMID:11121072]

Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Segu, L., Buhot, M. C. and Hen, R. (1994) 
Enhanced aggressive behavior in mice lacking 5-HT1B receptor.
Science, 265: 1875-1878. [PMID:8091214]

Schaerlinger, B., Hickel, P., Etienne, N., Guesnier, L. and Maroteaux, L. (2003) 
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.
Br J Pharmacol, 140: 277-284. [PMID:12970106]

Schechter, LE; Lin, Q; Smith, DL; Zhang, G; Shan, Q; Platt, B; Brandt, MR; Dawson, LA; Cole, D; Bernotas, R; et al.. (2008) 
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
Neuropsychopharmacology, 33 (6): 1323-35. [PMID:17625499]

Schmuck, K., Ullmer, C., Engels, P. and Lubbert, H. (1994) 
Cloning and functional characterization of the human 5-HT2B serotonin receptor.
FEBS Lett, 342: 85-90. [PMID:8143856]

Schotte, A., Janssen, P. F., Gommeren, W., Luyten, W. H., Van Gompel, P., Lesage, A. S., De Loore, K. and Leysen, J. E. (1996) 
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
Psychopharmacology (Berl), 124: 57-73. [PMID:8935801]

Selkirk, J. V., Scott, C., Ho, M., Burton, M. J., Watson, J., Gaster, L. M., Collin, L., Jones, B. J., Middlemiss, D. N. and Price, G. W. (1998) 
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
Br J Pharmacol, 125: 202-208. [PMID:9776361]

Serrats, J., Mengod, G. and Cortes, R. (2005) 
Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei.
J Chem Neuroanat, 29: 83-91. [PMID:15652696]

Shannon, H. E. and Lutz, E. A. (2000) 
Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors.
Psychopharmacology (Berl), 149: 93-97. [PMID:10789888]

Shapiro, D. A., Kristiansen, K., Kroeze, W. K. and Roth, B. L. (2000) 
Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
Mol Pharmacol, 58: 877-886. [PMID:11040033]

Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L. X., Sibley, D. R., Roth, B. L. and Mailman, R. (2003) 
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.
Neuropsychopharmacology, 28: 1400-1411. [PMID:12784105]

Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W. and Sibley, D. R. (1993) 
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
J Biol Chem, 268: 18200-18204. [PMID:8394362]

Shimron-Abarbanell, D., Nothen, M. M., Erdmann, J. and Propping, P. (1995) 
Lack of genetically determined structural variants of the human serotonin-1E (5-HT1E) receptor protein points to its evolutionary conservation.
Brain Res Mol Brain Res, 29: 387-390. [PMID:7609628]

Shippenberg, T. S., Hen, R. and He, M. (2000) 
Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor.
J Neurochem, 75: 258-265. [PMID:10854269]

Siddiqui, A., Abu-Amara, M., Aldairy, C., Hagan, J. J. and Wilson, C. (2004) 
5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
Eur J Pharmacol, 491: 77-84. [PMID:15102536]

Singer, J. H., Bellingham, M. C. and Berger, A. J. (1996) 
Presynaptic inhibition of glutamatergic synaptic transmission to rat motoneurons by serotonin.
J Neurophysiol, 76: 799-807. [PMID:8871200]

Sleight, A. J., Boess, F. G., Bos, M., Levet-Trafit, B., Riemer, C. and Bourson, A. (1998) 
Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-ht₆receptors.
Br. J. Pharmacol., 124: 556-562. [PMID:9647481]

Sleight, A. J., Stam, N. J., Mutel, V. and Vanderheyden, P. M. (1996) 
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Biochem Pharmacol, 51: 71-76. [PMID:8534270]

Soyka, M., Preuss, U. W., Koller, G., Zill, P. and Bondy, B. (2004) 
Association of 5-HT1B receptor gene and antisocial behavior in alcoholism.
J Neural Transm, 111: 101-109. [PMID:14714219]

Spedding, M., Newman-Tancredi, A., Millan, M. J., Dacquet, C., Michel, A. N., Jacoby, E., Vickery, B. and Tallentire, D. (1998) 
Interaction of the anxiogenic agent, RS-30199, with 5-HT1A receptors: modulation of sexual activity in the male rat.
Neuropharmacology, 37: 769-780. [PMID:9707291]

Sprouse, J., Reynolds, L., Braselton, J. and Schmidt, A. (2004) 
Serotonin-induced phase advances of SCN neuronal firing in vitro: a possible role for 5-HT5A receptors?.
Synapse, 54: 111-118. [PMID:15352136]

Sprouse, J., Reynolds, L., Li, X., Braselton, J. and Schmidt, A. (2004) 
8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
Neuropharmacology, 46: 52-62. [PMID:14654097]

Stam, N. J., Roesink, C., Dijcks, F., Garritsen, A., van Herpen, A. and Olijve, W. (1997) 
Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants.
FEBS Lett, 413: 489-494. [PMID:9303561]

Stam, N. J., Van Huizen, F., Van Alebeek, C., Brands, J., Dijkema, R., Tonnaer, J. A. and Olijve, W. (1992) 
Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes.
Eur J Pharmacol, 227: 153-162. [PMID:1330647]

Stam, N. J., Vanderheyden, P., Van Alebeek, C., Klomp, J., de Boer, T., van Delft, A. M. and Olijve, W. (1994) 
Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor.
Eur J Pharmacol, 269: 339-348. [PMID:7895773]

Stefulj, J., Jernej, B., Cicin-Sain, L., Rinner, I. and Schauenstein, K. (2000) 
mRNA expression of serotonin receptors in cells of the immune tissues of the rat.
Brain Behav Immun, 14: 219-224. [PMID:10970681]

Takeda, H., Tsuji, M., Ikoshi, H., Yamada, T., Masuya, J., Iimori, M. and Matsumiya, T. (2005) 
Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice.
Eur J Pharmacol, 518: 30-39. [PMID:16002064]

Terron, J. A. (1997) 
Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat.
Br J Pharmacol, 121: 563-571. [PMID:9179401]

Terron, J. A., Bouchelet, I. and Hamel, E. (2001) 
5-HT7 receptor mRNA expression in human trigeminal ganglia.
Neurosci Lett, 302: 9-12. [PMID:11278099]

Thomas, D. R., Gittins, S. A., Collin, L. L., Middlemiss, D. N., Riley, G., Hagan, J., Gloger, I., Ellis, C. E., Forbes, I. T. and Brown, A. M. (1998) 
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Br J Pharmacol, 124: 1300-1306. [PMID:9720804]

Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G., Stean, T., Scott, C. M., Hill, M. J., Middlemiss, D. N., Hagan, J. J., Price, G. W. and Forbes, I. T. (2003) 
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats.
Br J Pharmacol, 139: 705-714. [PMID:12812993]

Thomas, DR; Atkinson, PJ; Ho, M; Bromidge, SM; Lovell, PJ; Villani, AJ; Hagan, JJ; Middlemiss, DN; Price, GW. (2000) 
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.
Br. J. Pharmacol., 130 (2): 409-17. [PMID:10807680]

Thomsen, WJ; Grottick, AJ; Menzaghi, F; Reyes-Saldana, H; Espitia, S; Yuskin, D; Whelan, K; Martin, M; Morgan, M; Chen, W; et al.. (2008) 
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
J. Pharmacol. Exp. Ther., 325 (2): 577-87. [PMID:18252809]

Torres, G. E., Holt, I. L. and Andrade, R. (1994) 
Antagonists of 5-HT4 receptor-mediated responses in adult hippocampal neurons.
J Pharmacol Exp Ther., 271: 255-261. [PMID:7965722]

Trillat, A. C., Malagie, I., Scearce, K., Pons, D., Anmella, M. C., Jacquot, C., Hen, R. and Gardier, A. M. (1997) 
Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies.
J Neurochem, 69: 2019-2025. [PMID:9349547]

Tuladhar, B. R., Costall, B. and Naylor, R. J. (1996) 
Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum.
Br J Pharmacol, 119: 303-310. [PMID:8886413]

Tuo, B. G., Sellers, Z., Paulus, P., Barrett, K. E. and Isenberg, J. I. (2004) 
5-HT induces duodenal mucosal bicarbonate secretion via cAMP- and Ca2+-dependent signaling pathways and 5-HT4 receptors in mice.
Am J Physiol Gastrointest Liver Physiol, 286: G444-G451. [PMID:14576083]

Van den Wyngaert, I., Gommeren, W., Verhasselt, P., Jurzak, M., Leysen, J., Luyten, W. and Bender, E. (1997) 
Cloning and expression of a human serotonin 5-HT4 receptor cDNA.
J Neurochem., 69: 1810-1819. [PMID:9349523]

Vanover, K. E., Harvey, S. C., Son, T., Bradley, S. R., Kold, H., Makhay, M., Veinbergs, I., Spalding, T. A., Weiner, D. M., Andersson, C. M., Tolf, B. R., Brann, M. R., Hacksell, U. and Davis, R. E. (2004) 
Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-aceta mide hydrochloride]: a selective serotonin 2A receptor inverse agonist.
J Pharmacol Exp Ther, 310: 943-951. [PMID:15102927]

Varnas, K., Hall, H., Bonaventure, P. and Sedvall, G. (2001) 
Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743.
Brain Res., 915: 47-57. [PMID:11578619]

Varnas, K., Hurd, Y. L. and Hall, H. (2005) 
Regional expression of 5-HT1B receptor mRNA in the human brain.
Synapse, 56: 21-28. [PMID:15700286]

Vilaro, M. T., Cortes, R. and Mengod, G. (2005) 
Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions.
J Comp Neurol, 484: 418-439. [PMID:15770652]

Vilaro, M. T., Cortes, R., Gerald, C., Branchek, T. A., Palacios, J. M. and Mengod, G. (1996) 
Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry.
Brain Res Mol Brain Res, 43: 356-360. [PMID:9037555]

Vilaro, M. T., Domenech, T., Palacios, J. M. and Mengod, G. (2002) 
Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants.
Neuropharmacology., 42: 60-73. [PMID:11750916]

Voigt, M. M., Laurie, D. J., Seeburg, P. H. and Bach, A. (1991) 
Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor.
Embo J, 10: 4017-4023. [PMID:1836757]

Wacker, D; Wang, C; Katritch, V; Han, GW; Huang, XP; Vardy, E; McCorvy, JD; Jiang, Y; Chu, M; Siu, FY; et al.. (2013) 
Structural Features for Functional Selectivity at Serotonin Receptors.
Science,  [Epub ahead of print]. [PMID:23519215]

Waeber, C., Sebben, M., Grossman, C., Javoy-Agid, F., Bockaert, J. and Dumuis, A. (1993) 
[3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain.
Neuroreport., 4: 1239-1242. [PMID:8219020]

Waeber, C., Sebben, M., Nieoullon, A., Bockaert, J. and Dumuis, A. (1994) 
Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain.
Neuropharmacology, 33: 527-541. [PMID:7984292]

Wainscott, D. B., Cohen, M. L., Schenck, K. W., Audia, J. E., Nissen, J. S., Baez, M., Kursar, J. D., Lucaites, V. L. and Nelson, D. L. (1993) 
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Mol Pharmacol, 43: 419-426. [PMID:8450835]

Wainscott, D. B., Krushinski, J. H., Audia, J. E., Schaus, J. M., Zgombick, J. M., Lucaites, V. L. and Nelson, D. L. (2005) 
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
Naunyn Schmiedebergs Arch Pharmacol, 371: 169-177. [PMID:15900510]

Wainscott, D. B., Sasso, D. A., Kursar, J. D., Baez, M., Lucaites, V. L. and Nelson, D. L. (1998) 
[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Naunyn Schmiedebergs Arch Pharmacol, 357: 17-24. [PMID:9459568]

Wang, C; Jiang, Y; Ma, J; Wu, H; Wacker, D; Katritch, V; Han, GW; Liu, W; Huang, XP; Vardy, E; et al.. (2013) 
Structural Basis for Molecular Recognition at Serotonin Receptors.
Science,  [Epub ahead of print]. [PMID:23519210]

Wang, Z. Y., Keith, I. M., Beckman, M. J., Brownfield, M. S., Vidruk, E. H. and Bisgard, G. E. (2000) 
5-HT5a receptors in the carotid body chemoreception pathway of rat.
Neurosci Lett, 278: 9-12. [PMID:10643788]

Ward, S. E., Harrington, F. P., Gordon, L. J., Hopley, S. C., Scott, C. M. and Watson, J. M. (2005) 
Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.
J Med Chem, 48: 3478-3480. [PMID:15887956]

Watson, J. M., Burton, M. J., Price, G. W., Jones, B. J. and Middlemiss, D. N. (1996) 
GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors.
Eur J Pharmacol, 314: 365-372. [PMID:8957260]

Watson, J., Brough, S., Coldwell, M. C., Gager, T., Ho, M., Hunter, A. J., Jerman, J., Middlemiss, D. N., Riley, G. J. and Brown, A. M. (1998) 
Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
Br J Pharmacol, 125: 1413-1420. [PMID:9884068]

Watson, J., Roberts, C., Scott, C., Kendall, I., Collin, L., Day, N. C., Harries, M. H., Soffin, E., Davies, C. H., Randall, A. D., Heightman, T., Gaster, L., Wyman, P., Parker, C., Price, G. W. and Middlemiss, D. N. (2001) 
SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Br J Pharmacol, 133: 797-806. [PMID:11454652]

Watts, S. W. and Thompson, J. M. (2004) 
Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
J Pharmacol Exp Ther, 309: 165-172. [PMID:14724222]

Watts, S. W., Gilbert, L. and Webb, R. C. (1995) 
5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats.
Hypertension, 26: 1056-1059. [PMID:7498967]

Weinshank, R. L., Zgombick, J. M., Macchi, M. J., Branchek, T. A. and Hartig, P. R. (1992) 
Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT_1Dα and 5-HT_1Dβ.
Proc. Natl. Acad. Sci. U.S.A., 89: 3630-3634. [PMID:1565658]

Weiss, H. M., Haase, W., Michel, H. and Reilander, H. (1995) 
Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization.
FEBS Lett, 377: 451-456. [PMID:8549774]

Weydert, A., Cloez-Tayarani, I., Fillion, M. P., Simon-Chazottes, D., Guenet, J. L. and Fillion, G. (1992) 
Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig.
C R Acad Sci III, 314: 429-435. [PMID:1521164]

Whale, R., Bhagwagar, Z. and Cowen, P. J. (1999) 
Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?.
Psychopharmacology (Berl), 145: 223-226. [PMID:10463324]

Wolff, M., Benhassine, N., Costet, P., Hen, R., Segu, L. and Buhot, M. C. (2003) 
Delay-dependent working memory impairment in young-adult and aged 5-HT1BKO mice as assessed in a radial-arm water maze.
Learn Mem, 10: 401-409. [PMID:14557613]

Woolley, M. L., Bentley, J. C., Sleight, A. J., Marsden, C. A. and Fone, K. C. (2001) 
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.
Neuropharmacology, 41: 210-219. [PMID:11489457]

Wurch, T; Colpaert, FC; Pauwels, PJ. (1998) 
Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
Mol. Pharmacol., 54 (6): 1088-96. [PMID:9855638]

Xie, Z; Lee, SP; O'Dowd, BF; George, SR. (1999) 
Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed.
FEBS Lett., 456 (1): 63-7. [PMID:10452531]

Yang, W., Chen, K., Lan, N. C., Gallaher, T. K. and Shih, J. C. (1992) 
Gene structure and expression of the mouse 5-HT2 receptor.
J Neurosci Res, 33: 196-204. [PMID:1333538]

Yoshioka, M., Matsumoto, M., Togashi, H., Mori, K. and Saito, H. (1998) 
Central distribution and function of 5-HT6 receptor subtype in the rat brain.
Life Sci, 62: 1473-1477. [PMID:9585121]

Yu, L., Nguyen, H., Le, H., Bloem, L. J., Kozak, C. A., Hoffman, B. J., Snutch, T. P., Lester, H. A., Davidson, N. and Lubbert, H. (1991) 
The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked.
Brain Res Mol Brain Res, 11: 143-149. [PMID:1661811]

Zgombick, J. M. and Branchek, T. A. (1998) 
Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
Naunyn Schmiedebergs Arch Pharmacol, 358: 503-508. [PMID:9840417]

Zgombick, J. M., Schechter, L. E., Macchi, M., Hartig, P. R., Branchek, T. A. and Weinshank, R. L. (1992) 
Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
Mol Pharmacol, 42: 180-185. [PMID:1513320]

Zhang, J. Y., Nawoschik, S., Kowal, D., Smith, D., Spangler, T., Ochalski, R., Schechter, L. and Dunlop, J. (2003) 
Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.
Eur J Pharmacol, 472: 33-38. [PMID:12860470]